Kline Ashley Hartmann 4
4 · PALVELLA THERAPEUTICS, INC. · Filed Jun 3, 2025
Insider Transaction Report
Form 4
Kline Ashley Hartmann
Chief Commercial Officer
Transactions
- Award
Incentive Stock Option (right to buy)
2025-05-27+17,436→ 17,436 totalExercise: $22.94Exp: 2035-05-26→ Common Stock (17,436 underlying) - Award
Non-Qualified Stock Option (right to buy)
2025-05-27+111,496→ 111,496 totalExercise: $22.94Exp: 2035-05-26→ Common Stock (111,496 underlying)
Footnotes (1)
- [F1]The option vests 25% on May 27, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer as of each such vesting date.